---
title: "Adagio Medical Holdings, Inc. (ADGM.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/ADGM.US.md"
symbol: "ADGM.US"
name: "Adagio Medical Holdings, Inc."
industry: "Health Care Equipment"
datetime: "2026-05-20T14:35:13.344Z"
locales:
  - [en](https://longbridge.com/en/quote/ADGM.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ADGM.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ADGM.US.md)
---

# Adagio Medical Holdings, Inc. (ADGM.US)

## Company Overview

Adagio Medical Holdings, Inc., a medical technology company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, and ventricular tachycardia. The company’s product portfolio includes iCLAS atrial ultra-low temperature ablation (ULTA) catheter and system; vCLAS ventricular ULTC catheter; and Cryopulse pulsed field cryoablation catheters. Adagio Medical Holdings, Inc.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | US Market |
| Website | [adagiomedical.com](https://adagiomedical.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: E
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:15.000Z

**Overall: E (0.92)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 0 / 183 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: E

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 0.00% |  |
| Net Profit YoY | 67.40% |  |
| P/B Ratio | 3.24 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 18545733.27 |  |
| Revenue | 0.00 |  |

#### Multi Score Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -210.36% | E |
| Profit Margin | -57771.53% | E |
| Gross Margin | 0.00% | E |
| Revenue YoY | -74.77% | E |
| Net Profit YoY | -201.02% | E |
| Total Assets YoY | -70.57% | E |
| Net Assets YoY | -101.71% | E |
| Cash Flow Margin | -0.17% | D |
| OCF YoY | -74.77% | E |
| Turnover | 0.00 | E |
| Gearing Ratio | 104.16% | E |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Adagio Medical Holdings, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "0.00%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "67.40%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "3.24",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "18545733.27",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "0.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "E",
      "indicators": [
        {
          "name": "ROE",
          "value": "-210.36%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-57771.53%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "0.00%",
          "rating": "E"
        },
        {
          "name": "Revenue YoY",
          "value": "-74.77%",
          "rating": "E"
        },
        {
          "name": "Net Profit YoY",
          "value": "-201.02%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "-70.57%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "-101.71%",
          "rating": "E"
        },
        {
          "name": "Cash Flow Margin",
          "value": "-0.17%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "-74.77%",
          "rating": "E"
        },
        {
          "name": "Turnover",
          "value": "0.00",
          "rating": "E"
        },
        {
          "name": "Gearing Ratio",
          "value": "104.16%",
          "rating": "E"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.76 | 80/183 | - | - | - |
| PB | 3.24 | 79/183 | 2.89 | 2.11 | 1.59 |
| PS (TTM) | 191.70 | - | 162.33 | 121.67 | 41.39 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Delcath (DCTH.US) | C | A | B | A | A | A |
| 02 | Electromed (ELMD.US) | A | B | A | A | B | A |
| 03 | Intuitive Surgical (ISRG.US) | A | B | C | A | B | B |
| 04 | Stryker (SYK.US) | A | C | C | C | B | B |
| 05 | Boston Scientific (BSX.US) | A | B | C | C | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-12T04:00:00.000Z

Total Analysts: **2**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 1 | 50% |
| Overweight | 1 | 50% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 1.22 |
| Highest Target | undefined |
| Lowest Target | undefined |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/ADGM.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/ADGM.US/norm.md)
- [Related News](https://longbridge.com/en/quote/ADGM.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/ADGM.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**